These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3931915)

  • 1. Effect of cyclic estradiol valerate/levonorgestrel on periclimacteric syndrome and endometrial cytology.
    Castiglione A; Bierschwale M; Novoa O
    Clin Ther; 1985; 7(5):555-8. PubMed ID: 3931915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with a low-dose combination of estradiol valerate and levonorgestrel. Double-blind comparative study between SH D 386 F and Cyclabil. Effects on symptoms, lipids and endometrial condition.
    Lagrelius A; Fredricsson B; Hirt M; Weintraub L
    Acta Obstet Gynecol Scand Suppl; 1986; 134():97-101. PubMed ID: 3101396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
    Meuwissen JH; Beijers-De Bie L; Vihtamaki T; Tuimala R; Siseles N; Magaril C; The HS; Houben PW; Murga M; Spielmann D; De Villiers TJ
    Gynecol Endocrinol; 2001 Oct; 15(5):349-58. PubMed ID: 11727357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy.
    Chittacharoen A; Domhardt R; Manonai J; Theppisai U; Golbs S
    J Med Assoc Thai; 2004 Jan; 87(1):1-7. PubMed ID: 14971528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
    Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
    Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of estradiol valerate and levonorgestrel on vaginal health.
    Manonai J; Chittacharoen A; Theppisai U
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):190-3. PubMed ID: 15262354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial effects of a continuous percutaneous oestrogen/low dose oral progestogen regimen for climacteric complaints.
    Holst J; Cajander S; von Schoultz B
    Maturitas; 1987 Apr; 9(1):63-7. PubMed ID: 3110563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial safety with a low-dose intrauterine levonorgestrel-releasing system after 3 years of estrogen substitution therapy.
    Wildemeersch D; Schacht E; Wildemeersch P; Calleweart K; Pylyser K; De Wever N
    Maturitas; 2004 May; 48(1):65-70. PubMed ID: 15223110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study.
    Lundström E; Söderqvist G; Svane G; Azavedo E; Olovsson M; Skoog L; von Schoultz E; von Schoultz B
    Fertil Steril; 2006 Apr; 85(4):989-95. PubMed ID: 16580385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine or oral administration of levonorgestrel in combination with estradiol to perimenopausal women--effects on lipid metabolism during 12 months of treatment.
    Andersson K; Stadberg E; Mattsson LA; Rybo G; Samsioe G
    Int J Fertil Menopausal Stud; 1996; 41(5):476-83. PubMed ID: 8934257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uncertainties about the climacteric syndrome].
    Staland B
    Lakartidningen; 1990 Feb; 87(8):551. PubMed ID: 2308418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
    Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
    Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
    Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
    Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium--a randomized controlled trial.
    Valiati B; Capp E; Edelweiss MI; de Freitas FM; Wender MC
    Maturitas; 2009 Jan; 62(1):81-4. PubMed ID: 19097715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.
    Archer DF; Thorneycroft IH; Foegh M; Hanes V; Glant MD; Bitterman P; Kempson RL
    Menopause; 2005; 12(6):716-27. PubMed ID: 16278615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Estrogen-gestagen prevention and treatment of uterine hemorrhages in the premenopause].
    Rachev E; Katsarova M; Trepechov S
    Akush Ginekol (Sofiia); 1989; 28(3):78-81. PubMed ID: 2802089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
    Cameron ST; Glasier AF; Gebbie A; Dewart H; Baird DT
    Maturitas; 2006 Jan; 53(1):19-26. PubMed ID: 16325020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 micro g/ethinyl estradiol 20 micro g.
    Johnson JV; Grubb GS; Constantine GD
    Contraception; 2007 Jan; 75(1):23-6. PubMed ID: 17161119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serum lipids during treatment with norgestrel, oestradiol-valerate and cycloprogynon.
    Nielsen FH; Honoré E; Kristoffersen K; Secher NJ; Pedersen GT
    Acta Obstet Gynecol Scand; 1977; 56(4):367-70. PubMed ID: 602705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.